The treatment of candidemia.

The treatment of candidemia.

Bibliografische gegevens
Hoofdauteurs:	Tang, C, Howe, P, Crook, D
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	1995

Gelijkaardige items

Rare Conditions of Candidemia: Risk Factors and Outcomes for Mixed Candidemia and Late Recurrent Candidemia
door: Bahadır Orkun ÖZBAY, et al.
Gepubliceerd in: (2024-07-01)

Candidemia en Colombia
door: Jorge Alberto Cortés, et al.
Gepubliceerd in: (2020-03-01)

Active Surveillance of Candidemia, Australia
door: Sharon Chen, et al.
Gepubliceerd in: (2006-10-01)

Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
door: Coleman Rotstein, et al.
Gepubliceerd in: (2008-01-01)

Results of treatment for candidemia in patients with blood system tumors
door: G A Kliasova, et al.
Gepubliceerd in: (2013-11-01)

Impact of select risk factors on treatment outcome in adults with candidemia
door: Hill B, et al.
Gepubliceerd in: (2019-09-01)

Candidemia in Finland, 1995–1999
door: Eira Poikonen, et al.
Gepubliceerd in: (2003-08-01)

Candida dubliniensis Candidemia in Australia
door: Deborah Marriott, et al.
Gepubliceerd in: (2001-06-01)

Epidemiological Trends of Candidemia and the Impact of Adherence to the Candidemia Guideline: Six-Year Single-Center Experience
door: Jong Hun Kim, et al.
Gepubliceerd in: (2021-04-01)

Candidemia before and after the COVID-19 pandemic: An analysis of risk factors and outcomes in patients with candidemia
door: Nora Colburn, et al.
Gepubliceerd in: (2022-07-01)

Fisiopatogenia, epidemiologia e diagnóstico laboratorial da candidemia Phisiopathogenesis, epidemiology and laboratory diagnosis of candidemia
door: Muriel Padovani Giolo, et al.
Gepubliceerd in: (2010-06-01)

Results of candidemia treatment in children with hematologic malignancies: single center experience
door: I. I. Kalinina, et al.
Gepubliceerd in: (2014-07-01)

Results of candidemia treatment in children with hematologic malignancies: single center experience
door: I. I. Kalinina, et al.
Gepubliceerd in: (2014-07-01)

Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment
door: Lausch KR, et al.
Gepubliceerd in: (2018-11-01)

Clinical and epidemiological aspects of Candidemia in eight medical centers in the state of Parana, Brazil: Parana Candidemia Network
door: Carla Sakuma de Oliveira, et al.
Gepubliceerd in: (2021-01-01)

Intraleukocytic Candida is diagnostic of pathological candidemia
door: Anil Handoo, et al.
Gepubliceerd in: (2012-12-01)

Time of catheter removal in candidemia and mortality
door: Marcio Nucci, et al.

The Impact of Biofilm Formation on the Persistence of Candidemia
door: Wei-Sin Li, et al.
Gepubliceerd in: (2018-06-01)

The Epidemiology and Susceptibility of Candidemia in Jerusalem, Israel
door: Sarah Israel, et al.
Gepubliceerd in: (2019-10-01)

Candidemia em hospital terciário do nordeste do Brasil Candidemia in a tertiary hospital in northeastern Brazil
door: Sylvia Lemos Hinrichsen, et al.
Gepubliceerd in: (2008-08-01)

Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris
door: Daniele Roberto Giacobbe, et al.
Gepubliceerd in: (2023-02-01)

INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
door: Mingyue Sun, et al.
Gepubliceerd in: (2019-01-01)

Herpetic Whitlow: A Case Complicated with Candidemia
door: Canan Özlü, et al.
Gepubliceerd in: (2021-09-01)

Guideline Adherence and Outcomes of Patients with Candidemia in Brazil
door: Jordana Machado Araujo, et al.
Gepubliceerd in: (2024-04-01)

Risk Factors for Mortality in Colombian Patients with Candidemia
door: Jorge Alberto Cortés, et al.
Gepubliceerd in: (2021-05-01)

Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia
door: Roya Sattarzadeh Badkoubeh, et al.
Gepubliceerd in: (2022-08-01)

Biofilm: The invisible culprit in catheter-induced candidemia
door: Meiliyana Wijaya, et al.
Gepubliceerd in: (2023-05-01)

Risk factors for candidemia mortality in hospitalized children
door: Fabio Araujo Motta, et al.
Gepubliceerd in: (2017-03-01)

Comparisons of the clinical and mycological characteristics of pediatric candidemia
door: Wan-Chen Chen, et al.
Gepubliceerd in: (2022-09-01)

Risk factors for candidemia mortality in hospitalized children
door: Fabio Araujo Motta, et al.

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
door: Grau S, et al.
Gepubliceerd in: (2015-10-01)

Factors influencing recovery in patients with hemoblastoses and candidemia
door: G A Klyasova, et al.
Gepubliceerd in: (2015-07-01)

Risk factors for candidemia mortality in hospitalized children
door: Fabio Araujo Motta, et al.
Gepubliceerd in: (2017-03-01)

Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study
door: Cornelia Lass-Flörl, et al.
Gepubliceerd in: (2020-06-01)

De-escalation from Echinocandins to Azole Treatment in Critically Ill Patients with Candidemia
door: Jing Lin, et al.
Gepubliceerd in: (2022-08-01)

Correction: The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards.
door: PLOS ONE Staff
Gepubliceerd in: (2015-01-01)

The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].
door: Francesco G De Rosa, et al.
Gepubliceerd in: (2015-01-01)

Factores de riesgo asociados a candidemias causadas por múltiples especies Risk factors associated with multiple-species candidemia
door: A. Benetucci, et al.
Gepubliceerd in: (2008-03-01)

ACUTE PYELONEPHRITIS WITH CANDIDEMIA CAUSED BY FLUCONAZOLE RESISTANT CANDIDA ALBICANS
door: P. Periyasamy, et al.
Gepubliceerd in: (2023-08-01)

Incidence of candidemia and prevalence of azole-resistant candidemia at a tertiary South African hospital – A retrospective laboratory analysis 2016–2020
door: Vindana Chibabhai
Gepubliceerd in: (2022-02-01)